A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19

NCT04770467 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The study will no longer move forward due to recent changes in COVID-19 cases in Hong Kong.

Conditions

Interventions

Sponsor

Brii Biosciences, Inc.